Hill-Rom Holdings Inc (NYSE:HRC) issued an update on its fourth quarter earnings guidance on Friday morning. The company provided earnings per share (EPS) guidance of $1.26-1.30 for the period, compared to the Thomson Reuters consensus estimate of $1.33. The company issued revenue guidance of +3 to 4% to ~$727-734 million, compared to the consensus revenue estimate of $751.39 million.
Shares of Hill-Rom Holdings Inc (HRC) traded up 0.58% on Wednesday, hitting $74.87. 389,190 shares of the stock traded hands. The company has a market cap of $4.93 billion, a PE ratio of 43.63 and a beta of 1.22. The firm’s 50 day moving average is $79.14 and its 200-day moving average is $73.16. Hill-Rom Holdings Inc has a 12 month low of $50.50 and a 12 month high of $84.65.
Hill-Rom Holdings (NYSE:HRC) last released its quarterly earnings data on Friday, July 28th. The medical technology company reported $0.91 earnings per share for the quarter, beating the consensus estimate of $0.90 by $0.01. The business had revenue of $689.10 million for the quarter, compared to analyst estimates of $695.50 million. Hill-Rom Holdings had a return on equity of 19.99% and a net margin of 4.27%. The company’s revenue was up 5.1% compared to the same quarter last year. During the same period in the previous year, the company posted $0.81 EPS. Equities analysts predict that Hill-Rom Holdings Inc will post $3.82 earnings per share for the current year.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, September 29th. Stockholders of record on Friday, September 15th will be paid a $0.18 dividend. This represents a $0.72 annualized dividend and a dividend yield of 0.96%. The ex-dividend date of this dividend is Thursday, September 14th. Hill-Rom Holdings’s dividend payout ratio is currently 41.62%.
Several research firms have recently weighed in on HRC. Cantor Fitzgerald set a $86.00 price objective on Hill-Rom Holdings and gave the company a hold rating in a research note on Friday, July 28th. Zacks Investment Research lowered Hill-Rom Holdings from a buy rating to a hold rating in a research note on Tuesday, July 11th. BidaskClub lowered Hill-Rom Holdings from a strong-buy rating to a buy rating in a research report on Monday, July 24th. Morgan Stanley boosted their price target on Hill-Rom Holdings from $85.00 to $90.00 and gave the stock an overweight rating in a research report on Friday, June 30th. Finally, Barclays PLC boosted their price target on Hill-Rom Holdings from $70.00 to $75.00 and gave the stock an overweight rating in a research report on Wednesday, April 19th. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and five have assigned a buy rating to the stock. Hill-Rom Holdings currently has a consensus rating of Buy and an average price target of $88.17.
In related news, SVP Andreas G. Frank sold 10,660 shares of the business’s stock in a transaction that occurred on Tuesday, June 6th. The stock was sold at an average price of $78.62, for a total transaction of $838,089.20. Following the transaction, the senior vice president now directly owns 28,988 shares of the company’s stock, valued at approximately $2,279,036.56. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 2.20% of the company’s stock.
COPYRIGHT VIOLATION WARNING: This article was reported by StockNewsTimes and is the sole property of of StockNewsTimes. If you are viewing this article on another domain, it was copied illegally and reposted in violation of international copyright and trademark law. The correct version of this article can be accessed at https://stocknewstimes.com/2017/08/16/hill-rom-holdings-inc-hrc-issues-q4-earnings-guidance-updated-updated.html.
About Hill-Rom Holdings
Hill-Rom Holdings, Inc is a global medical technology company. The Company operates through four segments: North America Patient Support Systems, International Patient Support Systems, Front Line Care and Surgical Solutions. The Company’s products and services include Patient Support Systems, Front Line Care and Surgical Solutions.
Receive News & Ratings for Hill-Rom Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom Holdings Inc and related companies with MarketBeat.com's FREE daily email newsletter.
